Advert - Colonis
- 
                        Date posted25 September 2020
 - 
                            SanctionAdvertisement,
 - 
                            Case number/s
 
For sending a letter that promoted Melatonin 1mg/ml oral solution for off-label use and prejudiced patient safety, Colonis was ruled in breach of the following clauses of the Code:
Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry
Clause 3.2 - Promoting a medicine for an unlicensed indication
Clause 9.1 - Failing to maintain high standards